Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Koolen, Bas B.
200  Ergebnisse:
Personensuche X
?
1

Additional value of 18F-FDG PET/CT response evaluation in a..:

van Ramshorst, Mette S. ; Teixeira, Suzana C. ; Koolen, Bas B....
Cancer Imaging.  17 (2017)  1 - p. , 2017
Link: https://doi.org/10.1186/..
 
?
2

Combined use of 18F-FDG PET/CT and MRI for response monitor..:

Pengel, Kenneth E. ; Koolen, Bas B. ; Loo, Claudette E....
European Journal of Nuclear Medicine and Molecular Imaging.  41 (2014)  8 - p. 1515-1524 , 2014
Link: https://doi.org/10.1007/..
 
?
3

Sequential 18F-FDG PET/CT for early prediction of complete ..:

Koolen, Bas B. ; Pengel, Kenneth E. ; Wesseling, Jelle...
European Journal of Nuclear Medicine and Molecular Imaging.  41 (2013)  1 - p. 32-40 , 2013
Link: https://doi.org/10.1007/..
 
?
4

Pre-chemotherapy 18F-FDG PET/CT upstages nodal stage in sta..:

Koolen, Bas B. ; Valdés Olmos, Renato A. ; Vogel, Wouter V....
Breast Cancer Research and Treatment.  141 (2013)  2 - p. 249-254 , 2013
Link: https://doi.org/10.1007/..
 
?
5

Does the pretreatment tumor sampling location correspond wi..:

Koolen, Bas B. ; Elshof, Lotte E. ; Loo, Claudette E....
European Journal of Radiology.  82 (2013)  12 - p. 2353-2358 , 2013
Link: https://doi.org/10.1016/..
 
?
6

Reply to "Anti-cytokeratin CAM5.2 Recognized CK8 Mainly, bu..:

Koolen, Bas B. ; Wesseling, Jelle
Annals of Surgical Oncology.  21 (2013)  2 - p. 700-700 , 2013
Link: https://doi.org/10.1245/..
 
?
7

FDG PET/CT during neoadjuvant chemotherapy may predict resp..:

Koolen, Bas B. ; Pengel, Kenneth E. ; Wesseling, Jelle...
The Breast.  22 (2013)  5 - p. 691-697 , 2013
Link: https://doi.org/10.1016/..
 
?
8

Early Assessment of Axillary Response with 18F-FDG PET/CT d..:

Koolen, Bas B. ; Valdés Olmos, Renato A. ; Wesseling, Jelle...
Annals of Surgical Oncology.  20 (2013)  7 - p. 2227-2235 , 2013
Link: https://doi.org/10.1245/..
 
?
9

Association of perioperative troponin and atrial fibrillati..:

Koolen, Bas B. ; Labout, Joost A.M. ; Mulder, Paul G.H....
Interactive CardioVascular and Thoracic Surgery.  17 (2013)  4 - p. 608-614 , 2013
Link: https://doi.org/10.1093/..
 
?
10

Locoregional lymph node involvement on 18F-FDG PET/CT in br..:

Koolen, Bas B. ; Valdés Olmos, Renato A. ; Elkhuizen, Paula H. M....
Breast Cancer Research and Treatment.  135 (2012)  1 - p. 231-240 , 2012
Link: https://doi.org/10.1007/..
 
?
11

18F-FDG PET/CT as a staging procedure in primary stage II a..:

Koolen, Bas B. ; Vrancken Peeters, Marie-Jeanne T. F. D. ; Aukema, Tjeerd S....
Breast Cancer Research and Treatment.  131 (2011)  1 - p. 117-126 , 2011
Link: https://doi.org/10.1007/..
 
?
12

FDG-avid sclerotic bone metastases in breast cancer patient..:

Koolen, Bas B. ; Vegt, Erik ; Rutgers, Emiel J. Th....
Annals of Nuclear Medicine.  26 (2011)  1 - p. 86-91 , 2011
Link: https://doi.org/10.1007/..
 
?
13

Additional value of (18)F-FDG PET/CT response evaluation in..:

van Ramshorst, Mette S ; Teixeira, Suzana C ; Koolen, Bas B...
1470-7330.  , 2017
Link: https://dspace.library.u..
 
?
14

Additional value of 18F-FDG PET/CT response evaluation in a..:

Mette S. van Ramshorst ; Suzana C. Teixeira ; Bas B. Koolen...
http://link.springer.com/article/10.1186/s40644-017-0117-5.  , 2017
Link: https://doi.org/10.1186/..
 
?
15

Cost-Neutral Optimization of Pazopanib Exposure by Splittin..:

The Dutch Pharmacology Oncology Group (DPOG) ; Groenland, Stefanie L. ; van Eerden, Ruben A. G....
Clinical Pharmacokinetics.  59 (2020)  7 - p. 941-948 , 2020
Link: https://doi.org/10.1007/..
 
1-15